Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
18 Month Follow-up Visit of High Risk Infants (FU)
This study is currently recruiting participants.
Verified by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), November 2008
Sponsored by: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
ClinicalTrials.gov Identifier: NCT00009633
  Purpose

The NICHD Neonatal Research Network's Follow-Up study is a multi-center cohort in which surviving extremely low birth-weight infants (approximately 2 pounds) born in participating Network centers will receive neurodevelopmental, neurosensory and functional assessment at 18-22 months corrected age. Data regarding pregnancy and neonatal outcome are collected prospectively. The goal of the study is to identify maternal and neonatal risk and protective factors for neurodevelopmental outcome.


Condition Phase
Infant, Newborn
Infant, Low Birth Weight
Infant, Small for Gestational Age
Infant, Premature
Phase IV

U.S. FDA Resources
Study Type: Observational
Study Design: Cohort, Prospective
Official Title: 18 Month Follow-up Visit of High Risk Infants

Further study details as provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 68000
Study Start Date: January 1993
Estimated Study Completion Date: March 2011
Estimated Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
1
All infants included in the database.

Detailed Description:

A multi-center cohort study in which surviving extremely low birth-weight infants undergo neurodevelopmental, neurosensory and functional assessment at 18-22 months corrected age. Data regarding pregnancy and neonatal outcome are collected prospectively. Social and economic status information (SES) and a detailed interim medical history are obtained at the time of the assessment. The scheduled evaluations at 18 - 22 months corrected age include: demographic information; socioeconomic status; medical history; medications; medical equipment required; growth data; a detailed neurologic examination; Bayley Scales of Infant Development (mental, motor, infant behavior); Family Resource Scale; Stein Functional Status II Measure and the Stein Impact on the Family Scale.

The goal of the study is to identify maternal and neonatal risk and protective factors for neurodevelopmental outcome. Additional objectives of the study include: to characterize development in the areas of motor skills, cognitive skills, language and behavior; to determine the mortality and the prevalence of specific medical morbidities in ELBW infants; to characterize the relationship between growth and neurodevelopmental outcome; to assess the relationship between the socioeconomic status and developmental outcome; to identify significant family stress in this population and compliance with medical and developmental care; to assess the utilization of special support services and early intervention programs by this population; and finally, to evaluate the need for follow-up to school age. The Follow-Up Study has maintained its goal of greater than or equal to 80 percent follow-up compliance rate.

  Eligibility

Ages Eligible for Study:   18 Months to 24 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Infants inborn at NICHD NRN centers that are 401-1000 grams birth weight, and/or <29 weeks gestational age, OR infants enrolled in one or more additional NICHD NRN studies.

Criteria
  1. Infants inborn at NICHD NRN centers that are:

    • 401-1000 grams birth weight, and/or
    • 22 0/7 to 28 6/7 weeks (<29 weeks) gestational age
  2. Infants enrolled in one or more additional NICHD NRN Follow-up studies. For infants that do not meet the inclusion criteria above, inclusion and exclusion criteria are determined by the criteria for the additional trial(s). In these cases, infants that are larger than 1,000 grams and/or older than 29 weeks may be included in the FU Study.

Note: These inclusion criteria were changed as of 1/1/2008. Prior to this date, infants with birth weights between 401 and 1500 grams who were admitted to NRN NICUs within 14 days of birth were included in the database.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00009633

Contacts
Contact: Betty R. Vohr, MD (401) 274-1122 ext 1235 bvohr@wihri.org
Contact: Rosemary D. Higgins, MD 301-496-5575 higginsr@mail.nih.gov

Locations
United States, Alabama
University of Alabama at Birmingham Recruiting
Birmingham, Alabama, United States, 35233
Contact: Waldemar A. Carlo, MD     205-934-4680     wcarlo@peds.uab.edu    
Contact: Monica V. Collins, RN BSN     (205) 934-5771     mcollins@peds.uab.edu    
Principal Investigator: Waldemar A. Carlo, MD            
United States, California
Stanford University Recruiting
Palo Alto, California, United States, 94304
Contact: Krisa P. Van Meurs, MD     650-723-5711     vanmeurs@leland.stanford.edu    
Contact: M. Bethany Ball, BS CCRC     (650) 725-8342     mbball@stanford.edu    
Principal Investigator: Krisa P. Van Meurs, MD            
United States, Connecticut
Yale University Recruiting
New Haven, Connecticut, United States, 06504
Contact: Richard A. Ehrenkranz, MD     203-688-2895     richard.ehrenkranz@yale.edu    
Contact: Monica Konstantino, RN BSN     (203) 688-7987     monica.konstantino@yale.edu    
Principal Investigator: Richard A. Ehrenkranz, MD            
United States, Georgia
Emory University Recruiting
Atlanta, Georgia, United States, 30303
Contact: Barbara J. Stoll, MD     404-727-5740     barbara_stoll@oz.ped.emory.edu    
Contact: Ellen Hale, RN BS     (404) 616-4218     ellen_hale@oz.ped.emory.edu    
Principal Investigator: Barbara J. Stoll, MD            
Sub-Investigator: Shannon Hamrick, MD            
United States, Indiana
Indiana University Recruiting
Indianapolis, Indiana, United States, 46202
Contact: Brenda B. Poindexter, MD MS     317-274-3592     bpoindex@iupui.edu    
Contact: Leslie D. Wilson, RN BSN     (317) 274-8255     ldw@iupui.edu    
Principal Investigator: Brenda B. Poindexter, MD MS            
United States, Iowa
University of Iowa Recruiting
Iowa City, Iowa, United States, 52242
Contact: Edward F. Bell, MD     319-356-4006     edward-bell@uiowa.edu    
Contact: Karen J. Johnson, RN BSN     (319) 356-2924     karen-johnson@uiowa.edu    
Principal Investigator: Edward F. Bell, MD            
United States, Massachusetts
Tufts Medical Center Recruiting
Boston, Massachusetts, United States, 02111
Contact: Ivan D. Frantz III, MD     617-636-5322     ifrantz@tufts-nemc.org    
Contact: Brenda L. MacKinnon, RNC     (617) 636-1218     bmackinnon@tufts-nemc.org    
Principal Investigator: Ivan D. Frantz III, MD            
United States, Michigan
Wayne State University Recruiting
Detroit, Michigan, United States, 48201
Contact: Seetha Shankaran, MD     313-745-1436     sshankar@med.wayne.edu    
Contact: Rebecca Bara, RN BSN     (313) 745-1436     rbara@med.wayne.edu    
Principal Investigator: Seetha Shankaran, MD            
United States, New Mexico
University of New Mexico Recruiting
Albuquerque, New Mexico, United States, 87131
Contact: Kristi L. Watterberg, MD     505-272-3967     kwatterberg@salud.unm.edu    
Contact: Conra Backstrom Lacy, RN     (505) 272-0367     cbackstrom@salud.unm.edu    
Principal Investigator: Kristi L. Watterberg, MD            
United States, North Carolina
Duke University Recruiting
Durham, North Carolina, United States, 27710
Contact: Ronald N. Goldberg, MD     919-681-6025     goldb008@mc.duke.edu    
Contact: Katherine A. Foy     (919) 668-3360     foy00004@mc.duke.edu    
Principal Investigator: Ronald N. Goldberg, MD            
RTI International Recruiting
Durham, North Carolina, United States, 27705
Contact: Abhik Das, PhD     301-770-8214     adas@rti.org    
Contact: Kristin Zaterka-Baxter, RN     (919) 485-7750     kzaterka@rti.org    
Principal Investigator: Abhik Das, PhD            
United States, Ohio
Case Western Reserve University Recruiting
Cleveland, Ohio, United States, 44106
Contact: Michele C. Walsh, MD MS     216-844-3759     mcw3@cwru.edu    
Contact: Nancy S. Newman, BA RN     (216) 368-3084     nxs5@cwru.edu    
Principal Investigator: Michele C. Walsh, MD MS            
University of Cincinnati Recruiting
Cincinnati, Ohio, United States, 45267
Contact: Kurt Schibler, MD     513-636-3972     kurt.schibler@cchmc.org    
Contact: Cathy Grisby, BSN CCRC     (513) 558-4953     grisbyca@email.uc.edu    
Principal Investigator: Kurt Schibler, MD            
United States, Rhode Island
Brown University, Women & Infants Hospital of Rhode Island Recruiting
Providence, Rhode Island, United States, 02905
Contact: Abbot R. Laptook, MD     401-274-1122     alaptook@WIHRI.org    
Contact: Angelita Hensman     (401) 274-1122     ahensman@wihri.org    
Principal Investigator: Abbot R. Laptook, MD            
United States, Texas
University of Texas Southwestern Medical Center at Dallas Recruiting
Dallas, Texas, United States, 75235
Contact: Pablo J. Sanchez, MD     214-648-3753     Pablo.Sanchez@UTSouthwestern.edu    
Contact: Nancy A. Miller, RN     (214) 648-3780     Nancy.Miller@UTSouthwestern.edu    
Principal Investigator: Pablo J. Sanchez, MD            
United States, Utah
University of Utah Recruiting
Salt Lake City, Utah, United States, 84108
Contact: Roger G. Faix, MD     801-581-7052     roger.faix@hsc.utah.edu    
Contact: Karen A. Osborne, RN BSN     (801) 213-3298     karen.osborne@hsc.utah.edu    
Principal Investigator: Roger G. Faix, MD            
Sponsors and Collaborators
Investigators
Principal Investigator: Abbot R. Laptook, MD Brown University, Women & Infants Hospital of Rhode Island
Principal Investigator: Michele C. Walsh, MD MS Case Western Reserve University
Principal Investigator: Ronald N. Goldberg, MD Duke University
Principal Investigator: Barbara J. Stoll, MD Emory University
Principal Investigator: Brenda B. Poindexter, MD MS Indiana University
Principal Investigator: Abhik Das, PhD RTI International
Principal Investigator: Krisa P. Van Meurs, MD Stanford University
Principal Investigator: Ivan D. Frantz III, MD Tufts Medical Center
Principal Investigator: Kurt Schibler, MD University of Cincinnati
Principal Investigator: Waldemar A. Carlo, MD University of Alabama at Birmingham
Principal Investigator: Edward F. Bell, MD University of Iowa
Principal Investigator: Kristi L. Watterberg, MD University of New Mexico
Principal Investigator: Pablo J. Sanchez, MD University of Texas Southwestern Medical Center at Dallas
Principal Investigator: Kathleen A. Kennedy, MD MPH The University of Texas Health Science Center, Houston
Principal Investigator: Roger G. Faix, MD University of Utah
Principal Investigator: Seetha Shankaran, MD Wayne State University
Principal Investigator: Richard A. Ehrenkranz, MD Yale University
  More Information

Click here for more information on the NICHD Neonatal Research Network.  This link exits the ClinicalTrials.gov site

Publications of Results:
Walsh MC, Morris BH, Wrage LA, Vohr BR, Poole WK, Tyson JE, Wright LL, Ehrenkranz RA, Stoll BJ, Fanaroff AA; National Institutes of Child Health and Human Development Neonatal Research Network. Extremely low birthweight neonates with protracted ventilation: mortality and 18-month neurodevelopmental outcomes. J Pediatr. 2005 Jun;146(6):798-804.
Hintz SR, Kendrick DE, Vohr BR, Poole WK, Higgins RD; National Institute of Child Health and Human Development Neonatal Research Network. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999. Pediatrics. 2005 Jun;115(6):1645-51.
Hintz SR, Kendrick DE, Stoll BJ, Vohr BR, Fanaroff AA, Donovan EF, Poole WK, Blakely ML, Wright L, Higgins R; NICHD Neonatal Research Network. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics. 2005 Mar;115(3):696-703.
Laptook AR, O'Shea TM, Shankaran S, Bhaskar B; NICHD Neonatal Network. Adverse neurodevelopmental outcomes among extremely low birth weight infants with a normal head ultrasound: prevalence and antecedents. Pediatrics. 2005 Mar;115(3):673-80.
Hintz SR, Poole WK, Wright LL, Fanaroff AA, Kendrick DE, Laptook AR, Goldberg R, Duara S, Stoll BJ, Oh W; NICHD Neonatal Research Network. Changes in mortality and morbidities among infants born at less than 25 weeks during the post-surfactant era. Arch Dis Child Fetal Neonatal Ed. 2005 Mar;90(2):F128-33.
Ambalavanan N, Tyson JE, Kennedy KA, Hansen NI, Vohr BR, Wright LL, Carlo WA; National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics. 2005 Mar;115(3):e249-54. Epub 2005 Feb 15.
Stoll BJ, Hansen NI, Adams-Chapman I, Fanaroff AA, Hintz SR, Vohr B, Higgins RD; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004 Nov 17;292(19):2357-65.
Ohls RK, Ehrenkranz RA, Das A, Dusick AM, Yolton K, Romano E, Delaney-Black V, Papile LA, Simon NP, Steichen JJ, Lee KG; National Institute of Child Health and Human Development Neonatal Research Network. Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics. 2004 Nov;114(5):1287-91.
Castro L, Yolton K, Haberman B, Roberto N, Hansen NI, Ambalavanan N, Vohr BR, Donovan EF. Bias in reported neurodevelopmental outcomes among extremely low birth weight survivors. Pediatrics. 2004 Aug;114(2):404-10.
Vohr BR, Wright LL, Dusick AM, Perritt R, Poole WK, Tyson JE, Steichen JJ, Bauer CR, Wilson-Costello DE, Mayes LC; Neonatal Research Network. Center differences and outcomes of extremely low birth weight infants. Pediatrics. 2004 Apr;113(4):781-9.
Oh W, Tyson JE, Fanaroff AA, Vohr BR, Perritt R, Stoll BJ, Ehrenkranz RA, Carlo WA, Shankaran S, Poole K, Wright LL; National Institute of Child Health and Human Development Neonatal Research Network. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics. 2003 Oct;112(4):773-9.
Wadhawan R, Vohr BR, Fanaroff AA, Perritt RL, Duara S, Stoll BJ, Goldberg R, Laptook A, Poole K, Wright LL, Oh W. Does labor influence neonatal and neurodevelopmental outcomes of extremely-low-birth-weight infants who are born by cesarean delivery? Am J Obstet Gynecol. 2003 Aug;189(2):501-6.
Vohr BR, O'Shea M, Wright LL. Longitudinal multicenter follow-up of high-risk infants: why, who, when, and what to assess. Semin Perinatol. 2003 Aug;27(4):333-42. Review.
Dusick AM, Poindexter BB, Ehrenkranz RA, Lemons JA. Growth failure in the preterm infant: can we catch up? Semin Perinatol. 2003 Aug;27(4):302-10. Review.

Publications indexed to this study:
Responsible Party: Brown University, Women & Infants Hospital of Rhode Island ( Betty R. Vohr, Study Principal Investigator )
Study ID Numbers: NICHD-NRN-0006, U10 HD21364 (Case), U10 HD21373 (UT Houston), U10 HD21385 (Wayne State), U10 HD27851 (Emory), U10 HD27853 (Cincinnati), U10 HD27856 (Indiana), U10 HD27871 (Yale), U10 HD27880 (Stanford), U10 HD27904 (Brown), U10 HD34216 (Alabama), U10 HD36790 (RTI), U10 HD40492 (Duke), U10 HD40689 (UT Dallas), U10 HD53089 (New Mexico), U10 HD53109 (Iowa), U10 HD53119 (Tufts), U10 HD53124 (Utah), CCTS KL2 RR24149 (Houston), CCTS UL1 RR24128 (Duke), CCTS UL1 RR24139 (Yale), CCTS UL1 RR24148 (Houston), CCTS UL1 RR24979 (Iowa), CCTS UL1 RR24982 (Dallas), CCTS UL1 RR24989 (Case), CCTS UL1 RR25008 (Emory), GCRC M01 RR30 (Duke), GCRC M01 RR633 (Dallas), GCRC M01 RR64 (Utah), GCRC M01 RR70 (Stanford), GCRC M01 RR750 (Indiana), GCRC M01 RR80 (Case), GCRC M01 RR8084 (Cincinnati)
Study First Received: February 1, 2001
Last Updated: December 4, 2008
ClinicalTrials.gov Identifier: NCT00009633  
Health Authority: United States: Federal Government;   United States: Institutional Review Board

Keywords provided by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD):
NICHD Neonatal Research Network
Extremely Low Birth Weight (ELBW)
Prematurity
Neurodevelopmental Outcome
Follow up studies

Study placed in the following topic categories:
Body Weight
Birth Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on January 30, 2009